French English

Background

Nicolas Bouquin is a French and European patent attorney.

Nicolas worked for several years as a scientist, both in France and abroad, in academia and for a pharmaceutical company, before switching to intellectual property. After a few years as a patent attorney in a big pharma, Nicolas joined Regimbeau in 2009, where he assists his clients - from start-ups to big pharmas - in the protection and defense of their innovations in all aspects of life sciences and biotechnologies, with a particular focus on immunotherapy and antibodies.

Nicolas thus handlesh numerous French, European and foreign requests relating to complex biotechnology inventions. He has participated in multiple oppositions and appeals, in particular on issues related to antibodies.

Nicolas has a extensive experience advising on supplementary protection certificates (SPCs), in particular for gene or cell therapy products and antibodies.

Qualifications

  • French Patent Attorney
  • European Patent Attorney
  • Representative before the UPC

Education

  • Ph.D. “Genetics and Physiology of Microorganisms” (University of Paris XI)
  • CEIPI graduate ("patent")
  • DU CEIPI Patent Litigation in Europe
  • CEIPI Industrial Property Law LLM

Know-how

  • IP Audit
  • Acquisition of IP Rights & Strategy
  • IP Prosecution & Portfolio Management
  • Pre-litigation & Litigation
  • Freedom to operate

Related news

Rencontres - 22 Sep 2023

Medicen Day – September 26th, 2023  

Regimbeau will be present at Medicen Day, the annual event for the Paris region’s healthcare innovation network, on Tuesday September 26 in Paris!   Anne-Laure Deleuze and Nicolas Bouquin will be…

By Nicolas Bouquin, Ph.D and Anne-Laure Deleuze, Ph.D
Meetings - 18 Apr 2023

BIO International Convention – June 5-8, 2023 – Boston

Stéphanie Massin Célaire and Nicolas Bouquin will be attending the BIO International Convention, the world’s leading pharmaceutical and biotech industry event, which will be held in Boston from Monday, June…

By Stéphanie Massin Célaire and Nicolas Bouquin, Ph.D
Meetings - 22 Jun 2021

AIS 2021 – Protecting epitope versus paratope: Case study from Amgen PCSK9

Raphaëlle Gillet and Nicolas Bouquin will discuss the latest decisions regarding antibody patents and in particular the Amgen PCSK9 case at AIS 2021, on June 23rd 2021 at 2PM. Check…

By Nicolas Bouquin, Ph.D and Raphaëlle Gillet, Ph.D
Meetings - 11 Jul 2019

Immunotherapy Masterclasses

Contribution by Isabelle Mary et de Nicolas Bouquin at the Immunotherapy Masterclasses, organized by MabDesign.

By Isabelle Mary and Nicolas Bouquin, Ph.D
Meetings - 24 Jun 2019

AIS 2019

Contribution by Nicolas Bouquin, Senior Associate, French and European Patent Attorney, and Raphaëlle Gillet, French and European Patent Attorney to AIS 2019 congress.

By Raphaëlle Gillet, Ph.D and Nicolas Bouquin, Ph.D
Rencontres - 20 Jun 2019

Regimbeau IP ACADEMY 2019

Regimbeau is organising a 5-day training seminar on “European Patents and Designs: The Essentials” for clients and foreign colleagues wishing to acquire a working knowledge of the specificities of patent…

By Nicolas Bouquin, Ph.D Isabelle Thill Anne Seibel Cécile Puech, Ph.D Martine Bloch-Weill Armelle Leonard Frédérique Durieux Guillaume Schwab Sylvain Thivillier Yves de Saint-Pern Caroline Huguet-Braun and
Meetings - 04 Jun 2018

BIO International Convention

Participation of Frédérique Faivre Petit, Partner, and Nicolas Bouquin, Senior Associate, at the BIO International Convention.

By Frédérique Faivre Petit and Nicolas Bouquin, Ph.D
Rencontres - 05 Apr 2018

Regimbeau IP Academy 2018

Regimbeau is organising a 5-day training seminar on “European Patents and Designs: The Essentials” for clients and foreign colleagues wishing to acquire a working knowledge of the specificities of patent…

By Sylvain Thivillier Isabelle Thill Frédérique Faivre Petit Emmanuelle Levy Martine Bloch-Weill Nicolas Bouquin, Ph.D Frédérique Durieux Caroline Huguet-Braun Cécile Puech, Ph.D Anne Seibel Guillaume Schwab and